Technology And Equipment Tenders

Open House Biologika Discount Treaties 2025-09 - Lutropin Alfa / Follitropin Alfa (Combination of Active Ingredients)

Open House Biologika Discount Treaties 2025-10 - Choriongonadotropin Alfa

Open House Biologika Discount Treaties 2025-09 - Lutropin Alfa / Follitropin Alfa (Combination of Active Ingredients)

Open House Original Discount Contracts 2025-15 - Tacrolimus (Retard Tablets)

Abschluss nicht exkl. AM-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Glatirameracetat in der Darreichungsform PEN (ATC-Code nach WHO: L03AX13)

Abschluss nicht exkl. AM-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Glatirameracetat in der Darreichungsform Fertigspritze (ATC-Code nach WHO: L03AX13)

Open-House Biologika Discount Contracts 2025-08-Denosumab

Completion not Excl. According to Section 130A (8) Sgb V by an Open House Model to the Active Ingredient Glatirameracetate in the Dosage Form Pen (Atc Code According to Who: L03ax13)

Completion not Excl. According to Section 130A (8) Sgb V by Means of an Open House Model to the Active Ingredient Glatirameracetate in the Dosage Form.

Completion not Excl. Pharmaceutical Discount Club. According to Section 130A (8) Sgb V by Means of an Open House Model to the Active Ingredient Interferon Beta-1A (Atc Code According to Who: L03ab07)